XML 14 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
Jun. 30, 2018
Dec. 31, 2017
CURRENT ASSETS    
Cash and cash equivalents $ 20,579,000 $ 12,817,000
Marketable securities 51,614,000 37,482,000
Accounts receivable - grant 4,281,000 3,078,000
Prepaid expenses and other current assets 2,414,000 1,614,000
Total current assets 78,888,000 54,991,000
Property and equipment, net 776,000 854,000
Other non-current assets 49,000 232,000
TOTAL ASSETS 79,713,000 56,077,000
CURRENT LIABILITIES    
Accounts payable 952,000 389,000
Deferred revenue 0 20,000
Accrued and other current liabilities 5,223,000 5,220,000
Total current liabilities 6,175,000 5,629,000
Other non-current liabilities 91,000 111,000
TOTAL LIABILITIES 6,266,000 5,740,000
Commitments and Contingencies (Note 9)
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized as of June 30, 2018 and December 31, 2017; no shares issued and outstanding as of June 30, 2018 and December 31, 2017
Common stock, $0.0001 par value; 500,000,000 shares authorized as of June 30, 2018 and December 31, 2017; 21,908,192 shares and 16,670,188 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively 2,000 2,000
Additional paid-in capital 163,547,000 122,950,000
Accumulated other comprehensive loss (56,000) (102,000)
Accumulated deficit (90,046,000) (72,513,000)
TOTAL STOCKHOLDERS’ EQUITY 73,447,000 50,337,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 79,713,000 $ 56,077,000